Who took part in this study?
The researchers asked for the help of men and women with chronic lymphocytic
leukemia or small lymphocytic leukemia. The participants’ leukemia had either:
X come back or stopped responding to prior treatment, which is called
“relapsed/refractory”, or
X been high-risk and never treated before, which is called “treatment-naïve”
The participants in this study were 45 to 83 years old when they joined. The
study included 48 participants in the United States.
3 | Clinical Study Results